Ross Prize in Molecular Medicine Awarded to NIH Scientist Dr. John O’Shea
Celebration and symposium to be held at the New York Academy of Sciences on June 9.
Published April 24, 2014
NEW YORK, NY, April 24, 2014 - The Feinstein Institute for Medical Research today announced that John J. O'Shea, MD, scientific director at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), will be the recipient of the second annual Ross Prize in Molecular Medicine. The Prize, which includes a $50,000 gift, will be formally presented to Dr. O'Shea on June 9 at the New York Academy of Sciences, followed by an academic lecture by Dr. O'Shea and several other preeminent immunology researchers.
The Ross Prize is issued via the Feinstein Institute's peer-reviewed, open-access journal, Molecular Medicine is made possible by the generosity of Feinstein Institute board members Robin and Jack Ross of Upper Brookville, NY. It is awarded annually by Molecular Medicine to mid-career scientists who have made a demonstrable impact in the understanding of human diseases pathogenesis and/or treatment, and who hold significant promise for making even greater contributions to the general field of molecular medicine.
"John O'Shea turned his passion for clinical care into a successful research career pushing the frontiers of molecular medicine," says Feinstein Institute President, Kevin J. Tracey, MD, who also serves as editor-in-chief of Molecular Medicine. "His dedication and focus on the cytokine field have led to new treatments for immune diseases."
"It is very humbling to be awarded the 2014 Ross Prize in Molecular Medicine," says Dr. O'Shea. "From the beginning of my career, I was hoping to make discoveries that are important scientifically, but also directly help people-for me, it doesn't really get any better than that. It is very gratifying that my efforts to these ends are being recognized by this award."
On June 9, at a ceremony to be held at the Academy, Dr. O'Shea will be presented the Ross Prize. After the award presentation, John O'Shea; James P. Allison, PhD, The University of Texas, MD Anderson Cancer Center; Louis M. Staudt, MD, PhD, National Cancer Institute, NIH; and Charles A. Dinarello, MD, University of Colorado at Denver, will each present scientific lectures. These researchers will discuss the mechanisms of immune system function and signaling, which may improve the treatment for cancer and various autoimmune diseases.
To learn more about the Ross Prize celebration and symposium, visit www.nyas.org/RossPrize2014. For press inquiries, including press registration and interview requests, contact Diana Friedman (firstname.lastname@example.org; 212-298-8645).
# # #
About Molecular Medicine
Molecular Medicine is an open access, international, peer-reviewed biomedical journal published by The Feinstein Institute for Medical Research. Molecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. To learn more, go to www.molmed.org.
About The Feinstein Institute for Medical Research
Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer's disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 6th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit www.FeinsteinInstitute.org.
About the New York Academy of Sciences
The New York Academy of Sciences is an independent, not-for-profit organization that since 1817 has been committed to advancing science, technology, and society worldwide. With 22,000 members around the world, the Academy is creating a global community of science for the benefit of humanity. The Academy's core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. Please visit us online at www.nyas.org.